Cambrex Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Cambrex Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Cambrex Corporation. The Group's principal activity is providing technology-enhanced products and services to pharmaceutical companies and generic drug companies. It primarily comprised of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. It also provides essential products and services to drug discovery, development and manufacturing processes for human therapeutics. In January 2008, the Group acquired AS ProSyntest, a privately held API research and development company located in Tallinn, Estonia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report